NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

Email Format

{first_name}.{last_name}@neogenomics.com — 60.0%

sarah.smith@neogenomics.com

{first_letter_first_name}{last_name}@neogenomics.com — 40.0%

ssmith@neogenomics.com

Key Employees

Contact details of 14 NeoGenomics executives

Ryan J Angell

Vice President, Oncology Services and Laboratory Collaborations
  • Work email

    r*****l@neogenomics.com

David S Brooks

Divisional Vice President, Informatics
  • Work email

    d*****s@neogenomics.com

Ricky Kleinsmith

Associate Director of Quality Management Systems
  • Work email

    r*********h@neogenomics.com

Lakshmi Chandramohan

Principal Scientist, Associate Director, Molecular Assay Services
  • Work email

    l***********n@neogenomics.com

Kathryn B. McKenzie

Chief Financial Officer

Chris Smith

CEO

Byron Shen

Associate Director of Product Management, Pharma Services

Greg Sparks

Chief Technology Officer

Anna Juncker-Jensen

Principal Scientist, Associate Director Academic Collaborations

Steven A. Ross

Vice President, Chief Information Officer

Lynne Bauman

Senior Vice President

Tony Perez

Senior Vice President, Lab Operations

Marcus B. Silva,

Senior Vice-President, Commercial Growth

Warren Stone, MBA

President and Chief Operating Officer

Other Employees

Contact details of 5 NeoGenomics other employees

Sharon Kaufman

Job not specified
  • Work email

    s************n@neogenomics.com

First Last

Job not specified
  • Work email

    f********t@neogenomics.com

Kendra Sweeney

Job not specified
  • Work email

    k************y@neogenomics.com

Robert Gasparini

Consultant

Lynn A. Tetrault

Chair of the Board

General Emails

General company emails, e.g. customer support lines

    aimee.bui@neogenomics.com

    Unclassified inbox

    HR@neogenomics.com

    Human Resources Team

    hr@neogenomics.com

    Human Resources Team

    sjones@neogenomics.com

    Unclassified inbox

    sagersborg@neogenomics.com

    Unclassified inbox

Similar Companies like NeoGenomics

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices Hospitals & Clinics

Legal Name: Medtronic, plc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

Company Info

Last updated: 12/07/2025

(239) 768-0600

Fort Myers, Florida, United States

NeoGenomics General Information

Specialization: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Legal Name: NeoGenomics Laboratories, Inc.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (239) 768-0600
Last Investment Activity: Mar 18, 2024
Investments Activity: Mar 18, 2024 Feb 22, 2024 Feb 21, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.